Dr. Lennox is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
69 Jesse Hill Jr Dr SE
Faculty Office Building
Atlanta, GA 30303Phone+1 404-251-8784
Education & Training
- National Capital ConsortiumFellowship, Infectious Disease, 1986 - 1988
- National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
- University of Colorado School of Medicine Anschutz Medical CampusClass of 1983
Certifications & Licensure
- GA State Medical License 1994 - 2025
- CO State Medical License 1988 - 1995
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination Start of enrollment: 2006 Mar 01
- Comparative Study of Three NNRTI-Sparing HAART Regimens Start of enrollment: 2009 May 01
- Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy Start of enrollment: 2009 Apr 29
- Join now to see all
Publications & Presentations
PubMed
- 170 citationsDurable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results...Jürgen K. Rockstroh, Edwin DeJesus, Jeffrey L. Lennox, Yazdan Yazdanpanah, Michael S. Saag
Journal of Acquired Immune Deficiency Syndromes. 2013-05-01 - 204 citationsClinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious D...Gregory M. Lucas, Michael W. Ross, Peter G. Stock, Michael G. Shlipak, Christina M. Wyatt
Clinical Infectious Diseases. 2014-11-01 - 116 citationsClinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz-Containing Antiretroviral Therapy.Zeruesenay Desta, Roseann S. Gammal, Li Gong, Michelle Whirl-Carrillo, Aditya H. Gaur
Clinical Pharmacology and Therapeutics. 2019-10-01
Press Mentions
- Emory Receives NIH Funding for HIV Clinical Trials Unit, Including Four HIV/AIDS Clinical Research SitesDecember 1st, 2020
- Emory-CDC HIV Clinical Trials Group Leads Studies in Four Countries Through NIH NetworksDecember 1st, 2017
- Charlie Sheen Is Back on His HIV Meds After Seeking Alternative TreatmentsJanuary 13th, 2016
- Join now to see all
Grant Support
- Emory HIV/AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Clinical ResearchNational Institute Of Allergy And Infectious Diseases2007–2011
- ACTG A5211National Center For Research Resources2007
- ACTG A5202: HIV In Newly Infected SubjectsNational Center For Research Resources2007
- ACTG A5164National Center For Research Resources2007
- ACTG A5157National Center For Research Resources2007
- ACTG A5146National Center For Research Resources2007
- ACTG A5142National Center For Research Resources2007
- ACTG A5001: AllrtNational Center For Research Resources2007
- ACTG 362National Center For Research Resources2007
- A5210: Phase Ib/Iia Dose-Finding Safety And Activity Study Of Amd11070National Center For Research Resources2007
- Project 3: Clinical TrialsNational Center For Research Resources2003–2006
- Efavirenz, Nevirapine, Nevirapine, And Lopinavir/Ritonavir In HIV DialysisNational Center For Research Resources2005
- Project 3: Vaccine DevelopmentNational Center For Research Resources2004
- Clinical TrialsNational Institute Of Allergy And Infectious Diseases2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: